Agappe Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 6.13 Cr
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 128.15 Cr
- Satisfied Charges ₹ 33.19 Cr
- Revenue Growth -11.79%
- Profit Growth -76.05%
- Ebitda -67.49%
- Net Worth 3.49%
- Total Assets 29.86%
About Agappe Diagnostics
Agappe Diagnostics Limited (ADL) is a leading Public Limited Indian Non-Government Company incorporated in India on 18 June 1998 and has a history of 26 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Agappe Diagnostics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.13 Cr.
The company currently has active open charges totaling ₹128.15 Cr. The company has closed loans amounting to ₹33.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Agappe Diagnostics Limited India is Sreevidya M as COMPANY SECRETARY. Thomas John, Joseph Antony, Sangeeta Joseph, and Six other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
- CIN/LLPIN
U24239MH1998PLC115413
- Company No.
115413
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Jun 1998
- Date of AGM
14 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Agappe Diagnostics Limited offer?
Agappe Diagnostics Limited offers a wide range of products and services, including Medical Laboratory Instruments, IVDs & Analyzers, Hematology Analyzers, Analyzers & Analytical Instruments, Elemental Analyzer, Rapid Test Kit, Blood Group Test Kit, Medical Imaging Machine & Accessories, MRI Machine, Marking and Stamping Machines.
Who are the key members and board of directors at Agappe Diagnostics?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thomas John  | Managing Director | 18-Jun-1998 | Current |
| Sreevidya M | Company Secretary | 17-Aug-2015 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thomas Kalappila | Director | 18-Apr-2022 | Current |
| Rhema Thomas | Whole-Time Director | 10-May-2021 | Current |
| Joseph John | Director | 26-Sep-2017 | Current |
| Joseph Antony | Director | 30-Jun-2021 | Current |
| Sangeeta Joseph | Whole-Time Director | 15-Dec-2006 | Current |
| Meena Thomas | Whole-Time Director | 31-May-2007 | Current |
Financial Performance of Agappe Diagnostics.
Agappe Diagnostics Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.79% decrease. The company also saw a substantial fall in profitability, with a 76.05% decrease in profit. The company's net worth moved up by a moderate rise of 3.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agappe Diagnostics?
In 2023, Agappe Diagnostics had a promoter holding of 79.77% and a public holding of 20.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Viswasanthi Development FoundationDamodaran Vasudevan is a mutual person
Esaf Small Finance Bank LimitedJoseph Antony and Thomas Kalappila are mutual person
Attukal Devi Institute Of Medical Sciences LimitedDamodaran Vasudevan is a mutual person
Association Of Diagnostics Manufacturers Of IndiaThomas John is a mutual person
Spotmarkets Securities Private LimitedThomas Kalappila is a mutual person
- Syncon Management Consultants Pvt Ltd
Thomas Kalappila is a mutual person
Charges (Loans)
₹128.15 Cr
₹33.19 Cr
Charges Breakdown by Lending Institutions
- Others : 128.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2023 | Others | ₹15.00 Cr | Open |
| 04 Aug 2012 | Others | ₹113.15 Cr | Open |
| 16 Aug 2014 | The Federal Bank Ltd | ₹10.65 Cr | Satisfied |
| 03 Mar 2012 | The South Indian Bank Limited | ₹8.50 M | Satisfied |
| 21 Nov 2011 | The South Indian Bank Limited | ₹5.00 M | Satisfied |
How Many Employees Work at Agappe Diagnostics?
Agappe Diagnostics has a workforce of 929 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agappe Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agappe Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
